- Home
- AGL
as 03-27-2025 4:00pm EST
Agilon Health Inc is transforming healthcare by empowering primary care physicians for the health of the patients. The company enables physicians to create their own Medicare-centric globally capitated line of business. The company derives its revenue from Medical services.
| Founded: | 2016 | Country: | United States |
| Employees: | N/A | City: | AUSTIN |
| Market Cap: | 1.4B | IPO Year: | 2021 |
| Target Price: | $3.85 | AVG Volume (30 days): | 5.8M |
| Analyst Decision: | Hold | Number of Analysts: | 18 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.63 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.50 - $7.73 | Next Earning Date: | 05-06-2025 |
| Revenue: | $6,060,530,000 | Revenue Growth: | 40.41% |
| Revenue Growth (this year): | 2.12% | Revenue Growth (next year): | 13.99% |
Latest agilon health inc. News
AGL Breaking Stock News: Dive into AGL Ticker-Specific Updates for Smart Investing
Insider Monkey
a day ago
Agilon Health Inc. (NYSE:AGL): Amazing Performance So Far In 2025
Business Wire
2 days ago
agilon health Sets Date to Report First Quarter 2025 Financial Results
Zacks
7 days ago
Is Agilon Health (AGL) Stock Outpacing Its Medical Peers This Year?
Benzinga
9 days ago
Agilon Health Adjusts To Recovery Phase, Analyst Is Cautious On Near-Term Fundamentals
StockStory
15 days ago
Healthcare Providers & Services Stocks Q4 In Review: The Ensign Group (NASDAQ:ENSG) Vs Peers
StockStory
15 days ago
Outpatient & Specialty Care Stocks Q4 Results: Benchmarking U.S. Physical Therapy (NYSE:USPH)
StockStory
15 days ago
3 Growth Stocks with Explosive Upside
Simply Wall St.
22 days ago
Undervalued Small Caps With Insider Buying In The Region
Compare AGL vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "AGL agilon health inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.